These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1767121)

  • 1. [Wegener's granulomatosis. Therapeutic indications and follow-up course. Apropos of 5 cases].
    Urban T; Bréchot JM; Capron F; Allard P; Prudent J; Lebeau B; Rochemaure J
    Rev Mal Respir; 1991; 8(5):487-92. PubMed ID: 1767121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wegener's granulomatosis with renal involvement: a 14 year experience.
    Sizeland PC; Bailey RR; Lynn KL; Robson RA
    N Z Med J; 1990 Aug; 103(895):366-7. PubMed ID: 2385397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wegener's granulomatosis].
    Nalepa P; Niemiec A
    Pol Merkur Lekarski; 1997 Oct; 3(16):196-8. PubMed ID: 9461731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exophthalmos and cranial neuropathy as a form of presentation of Wegener's granulomatosis].
    Campello I; Sanjuán F; Brieva L; Losfablos F; Hermida I; Velilla J
    Neurologia; 1997 Apr; 12(4):168-71. PubMed ID: 9235025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A favorable result of immunosuppressive therapy combined with the use of cyclosporine in a case of particularly severe Wegener's granuloma].
    Krzemień S; Wacławik A; Hołowiecki J; Strzelczyk S
    Pol Tyg Lek; 1994 May 2-9; 49(18-19):429-32. PubMed ID: 7708573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wegener's granulomatosis: treatment failure on conventional therapy.
    Locht H; Lindström FD
    J Rheumatol; 1989 Apr; 16(4):544-6. PubMed ID: 2746596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Wegener's granulomatosis with sulfamethoxazole-trimethoprim.
    Valeriano-Marcet J; Spiera H
    Arch Intern Med; 1991 Aug; 151(8):1649-52. PubMed ID: 1872670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
    Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.
    Andrassy K; Erb A; Koderisch J; Waldherr R; Ritz E
    Clin Nephrol; 1991 Apr; 35(4):139-47. PubMed ID: 1855316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.
    Hagen EC; de Keizer RJ; Andrassy K; van Boven WP; Bruijn JA; van Es LA; van der Woude FJ
    Clin Nephrol; 1995 Jun; 43(6):351-9. PubMed ID: 7554518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
    Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
    Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term observations of Wegener's disease. Results of treating recurrences].
    Bohn T; Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1985 Apr; 110(16):642-4. PubMed ID: 3987524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide.
    Chapman PT; O'Donnell JL
    J Rheumatol; 1993 Mar; 20(3):504-6. PubMed ID: 8478858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.